Clinical Trial Update: TMJ NextGen Pilot Study to Treat Subjects With Bruxism [NA]

View source ↗

Summary

An update on Cardiox Corporation's TMJ NextGen pilot study for treating bruxism, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bruxism

Snippet

Sponsor: Cardiox Corporation | Conditions: Bruxism | NA | Status: UNKNOWN